MESSAGE FROM BEXIL
Letter from the President
Overview
    COMMUNICATIONS
Cautionary Language and Forward Looking Statements
Press Releases
Shareholder Reports and Proxy Statements
Rule 15c2-11 Information
Investor Conference Calls
    GOVERNANCE
Board of Directors
Executives
Other Governance Info
    CONTACT US
Contact Bexil
Contact Transfer Agent
 
 
 
 
 
 
 
 
 
 
 
 
 

Rule 15c2-11 Information

(A) The name of the issuer and any predecessors during the past five years: Bexil Corporation

(B) The address(es) of the issuer's principal executive office and of its principal place of business: 3814 Route 44, Millbrook, NY 12545

(C) The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years: Maryland

(D) The title, class, and ticker symbol (if assigned) of the security: Common Stock and Rights to Purchase Series A Participating Preferred Stock

(E) The par or stated value of the security:
        a. Common Stock: $.01 par value
        b. Rights to Purchase Series A Participating Preferred Stock: $.01 par value

(F) The number of shares or total amount of the securities outstanding as of the end of the issuer's most recent fiscal year: See the Company's most recent annual report.

(G) The name and address of the transfer agent: Securities Transfer Corporation, 2901 N. Dallas Parkway, Suite 380, Plano, Texas 75093

(H) A description of the issuer's business: See the Company's most recent annual report.

(I) A description of products or services offered by the issuer: See the Company's most recent annual report.

(J) A description and extent of the issuer's facilities: See the Company's most recent annual report.

(K) The name and title of all company insiders: See the Company's most recent annual report.

(L) The issuer's most recent balance sheet (as of a date less than 16 months before the publication or submission of the quotation) and profit and loss and retained earnings statements (for the 12 months preceding the date of the most recent balance sheet): See the Company's most recent annual report and Press Releases.

(M) Similar financial information for such part of the two preceding fiscal years as the issuer or its predecessors has been in existence: See the Company's most recent annual report and Press Releases.



3814 Route 44, Millbrook, NY 12545 Tel: 1-212-785-0900 Fax: 1-917-746-4802
Home   |   Contact
www.Bexil.com